» Articles » PMID: 24400842

Factors Predicting Failure of AV "fistula First" Policy in the Elderly

Overview
Journal Hemodial Int
Date 2014 Jan 10
PMID 24400842
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

An arteriovenous fistula (AVF) is the preferential hemodialysis (HD) access. The goal of this study was to identify factors associated with pre-dialysis AVF failure in an elderly HD population. We used United States Renal Data System + Medicare claims data to identify patients ≥ 67 years old who had an AVF as their initial vascular access placed pre-dialysis. Failure of the AVF to be used for initial HD, was used as the outcome. Logistic regression model was used to identify factors associated with AVF failure. The study cohort consisted of 20,360 subjects (76.2 ± 6.02 year old, 58.5% men). Forty-eight percent of patients initiated dialysis using an AVF, while 52% used a catheter or an AVG. The following variables found to be associated with AVF failure when an AVF was created at least 4 months pre-HD initiation: older age (odds ratio [OR] 1.01; 95% confidence interval [CI] 1.00-1.02), female gender (OR 1.69; 95% CI 1.55-1.83), black race (OR 1.41; 95% CI 1.26-1.58), history of diabetes (OR 1.22; 95% CI 1.06-1.39), cardiac failure (OR 1.26; 95% CI 1.15-1.37), and shorter duration of pre-end-stage renal disease (ESRD) nephrology care (OR for a nephrology care of less than 6 months prior to ESRD of 1.22 compared with a pre-ESRD nephrology follow up of more than 12 months; 95% CI 1.07-1.38). OR for AVF failure for the entire cohort showed similar findings. In an elderly HD population, there is an association of older age, female gender, black race, diabetes, cardiac failure and shorter pre-ESRD nephrology care with predialysis AVF failure.

Citing Articles

Association Between Atherosclerotic Cardiovascular Disease (ASCVD) Risk Score and Arteriovenous Fistula Failure in Patients on Maintenance Hemodialysis.

M G, Suresh S, Prakash A, G G, Elumalai R, Shekar M Cureus. 2024; 16(6):e62298.

PMID: 39006556 PMC: 11245744. DOI: 10.7759/cureus.62298.


Arteriovenous fistula creation by nephrologist and its outcomes: a prospective cohort study from Vietnam.

Nguyen B, Duong M, Diem Tran H, Do K, Nguyen K BMC Nephrol. 2023; 24(1):88.

PMID: 37016300 PMC: 10074789. DOI: 10.1186/s12882-023-03123-3.


Shared decision-making in hemodialysis vascular access practice.

Murea M, Grey C, Lok C Kidney Int. 2021; 100(4):799-808.

PMID: 34246655 PMC: 8463450. DOI: 10.1016/j.kint.2021.05.041.


The arteriovenous access stage (AVAS) classification.

Balaz P, Hanko J, Magowan H, Masengu A, Lawrie K, ONeill S Clin Kidney J. 2021; 14(7):1747-1751.

PMID: 34221382 PMC: 8243270. DOI: 10.1093/ckj/sfaa189.


The association of erythropoietin-stimulating agents and increased risk for AV-fistula dysfunction in hemodialysis patients. A retrospective analysis.

Warme A, Hadimeri H, Nasic S, Stegmayr B BMC Nephrol. 2021; 22(1):30.

PMID: 33461526 PMC: 7814716. DOI: 10.1186/s12882-020-02209-6.